13-Mar-2026
Chimera Investment Delivers Higher Return on Equity and Expands Agency MBS Exposure in 2025
Market Chameleon (Wed, 11-Feb 2:39 AM ET)
CHIMERA INVESTMENT CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2025 EARNINGS
Business Wire (Wed, 11-Feb 6:46 AM ET)
Business Wire (Wed, 11-Feb 6:45 AM ET)
Business Wire (Wed, 28-Jan 4:15 PM ET)
Chimera Declares Fourth Quarter 2025 Common Stock Dividend
Business Wire (Thu, 18-Dec 4:30 PM ET)
Chimera Investment Corporation is an internally managed REIT whose principal business objective is to provide attractive risk-adjusted returns and distributable income through investment performance linked to mortgage credit fundamentals. Through its mortgage lending, investment management, and advisory services platforms, the Company operates as a fully integrated mortgage business that originates, manages, and invests in a diversified range of mortgage assets. The Company invests, directly or indirectly, generally on a levered basis across a spectrum of mortgage assets, including residential mortgage loans, Non-Agency RMBS, Agency RMBS, Agency CMBS, MSRs, business purpose and investor loans, including RTLs, and other real estate-related assets.
Chimera Investment trades on the NYSE stock market under the symbol CIM.
As of March 13, 2026, CIM stock price declined to $13.09 with 642,248 million shares trading.
CIM has a beta of 0.67, meaning it tends to be less sensitive to market movements. CIM has a correlation of 0.15 to the broad based SPY ETF.
CIM has a market cap of $1.09 billion. This is considered a Small Cap stock.
Last quarter Chimera Investment reported $66 million in Revenue and $.53 earnings per share. This fell short of revenue expectation by $-15 million and exceeded earnings estimates by $.03.
In the last 3 years, CIM traded as high as $19.47 and as low as $9.85.
The top ETF exchange traded funds that CIM belongs to (by Net Assets): VTI, IWM, VB, VBR, REM.
CIM has underperformed the market in the last year with a price return of +9.4% while the SPY ETF gained +21.4%. However, in the short term, CIM had mixed performance relative to the market. It has outperformed in the last 3 months, returning +5.9% vs -2.6% return in SPY. But in the last 2 weeks, CIM shares have been beat by the market, returning -3.8% compared to an SPY return of -3.5%.
CIM support price is $12.90 and resistance is $13.41 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CIM shares will trade within this expected range on the day.